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Abstract
Background: Nanoparticles in contact with biological fluids interact with proteins and other biomolecules, thus forming a
dynamic corona whose composition varies over time due to continuous protein association and dissociation events.
Eventually equilibrium is reached, at which point the continued exchange will not affect the composition of the corona.
Results: We developed a simple and effective dynamic model of the nanoparticle protein corona in a body fluid, namely
human plasma. The model predicts the time evolution and equilibrium composition of the corona based on affinities,
stoichiometries and rate constants. An application to the interaction of human serum albumin, high density lipoprotein
(HDL) and fibrinogen with 70 nm N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles is presented,
including novel experimental data for HDL.
Conclusions: The simple model presented here can easily be modified to mimic the interaction of the nanoparticle protein
corona with a novel biological fluid or compartment once new data will be available, thus opening novel applications in
nanotoxicity and nanomedicine.
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Introduction
When nanoparticles enter a biological fluid, proteins and other
biomolecules compete for the nanoparticle surface, thus leading to
the formation of a protein corona that defines the biological
identity of the particle [1]. The corona is dynamic in nature and its
composition varies over time due to continuous protein association
and dissociation events. Eventually equilibrium is established, at
which point the concentrations of free and bound proteins are
such that for each protein the association and dissociation rates
have become equal and the continued exchange will not affect the
composition of the corona. However, the corona will again change
composition if the nanoparticle moves to another compartment or
fluid [2]. Particle material, size and surface properties have been
found to play a significant role in determining the composition of
the corona [1–4]. The term ‘‘hard corona’’ defines the long-lived
equilibrium state, representing a fingerprint of a nanoparticle in a
certain environment [2]. Understanding the time evolution of the
protein corona in a given biological fluid, and in particular the
time-scales on which particle-associated proteins exchange with
free proteins, enables predictions of the particle’s fate as regards
interactions with specific receptors or predictions of its life time in
blood. Such understanding will have impact both on nanomedi-
cine and on nanotoxicity.
In this work, we present a simple and effective mathematical
model that describes the kinetics of the corona formation around a
copolymer nanoparticle based on experimentally determined
association and dissociation rate constants. This is to our
knowledge the first attempt to model the competitive nanoparti-
cle-protein interaction kinetics that contributes to the formation of
the corona. Parameters determined in our previous studies [1–6]
and by surface plasmon resonance (SPR) measurements per-
formed in this study, as well as data taken from the literature, were
introduced in the model to describe the interaction of three human
plasma proteins with copolymer nanoparticles. The nanoparticles
used are synthetic N-iso-propylacrylamide/N-tert-butylacrylamide
(NIPAM/BAM) 50:50 copolymer nanoparticles of 70 nm diam-
eter. The three proteins investigated are human serum albumin
(HSA), high density lipoprotein (HDL) and fibrinogen (Fib). These
proteins were chosen because they have been found to be major
biological macromolecules in the corona around the copolymer
particles [1–4]. HDL is a complex composed of different proteins,
phospholipids, cholesterol and triglycerides. Cedervall et al.
showed that the corona around the copolymer particles contains
the apolipoproteins that build up HDL [1,3], and Hellstrand et al.
identified phospholipids in the corona in a range that suggests that
the intact HDL particle is interacting with the copolymer
nanoparticles [4]. The three proteins are found in human blood
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e10949at different concentrations, see Table 1, and have different
molecular sizes.
Results and Discussion
The number of binding sites on a nanoparticle will be
determined by the size of the particle as well as of the protein.
However, the hydrophobicity of the nanoparticle strongly
influences its protein binding properties [1,5]. Differences in the
nanoparticle surface chemistry may control the number of possible
binding sites. It is thus important to include in the model a factor
that accounts for the maximum number of available binding sites
on the nanoparticle surface for each specific protein. This is
expected to affect both the competition between different proteins
for the same nanoparticle and the maximum level of coverage of
the nanoparticle surface by each specific protein. Considering as a
first approximation each bound protein as a sphere physically in
contact with the nanoparticle surface, the ideal number of binding
sites ni for the protein i is given by the ratio between the extended
nanoparticle surface and the cross-section of a protein:
ni~
4p rNPzri ðÞ
2
pri
2 ð1Þ
where rNP is the nanoparticle radius, here 35 nm, and ri is the
protein radius if proteins are considered as spheres. The extended
rather than actual nanoparticle surface better describes the
available surface, since CD data indicate that proteins adsorb to
the copolymer nanoparticles in a native-like fashion (unpublished
data), so that the area of interest is the one that is one protein
radius above the nanoparticle surface.
The number of binding sites per protein type was included in
the association rate laws of each protein-nanoparticle reaction, to
serve as correction factors accounting for the maximum surface
occupancy of each protein. The geometrical quantities are
reported in Table 1, which further lists all the parameters
employed in the simulations.
In our previous experiments on HSA binding to the same type
of nanoparticles we found that the binding data were well fitted by
a simple binding model devoid of any apparent cooperativity or
inter-protein interaction phenomena [1]. Assuming that the same
mechanisms remain valid also for the other two proteins, the
reversible biochemical equations describing the dynamics of
the nanoparticle (NP)-protein interactions can be modeled as
follows:
NPzHSA/ ? NP:HSA
NPzHDL/ ? NP:HDL
NPzFib/ ? NP:Fib
ð2Þ
With the assumption of law of mass action kinetics, the
biochemical system can be modeled by a set of ordinary
differential equations (ODEs), and the time evolution of each
protein-nanoparticle complex can be assessed by numerically
solving the following ODE system:
dN P :HSA ½ 
dt
~nHSA kon
HSA NP ½  HSA ½  {k
off
HSA NP:HSA ½ 
dN P :HDL ½ 
dt
~nHDL kon
HDL NP ½  HDL ½  {k
off
HDL NP:HDL ½ 
dN P :Fib ½ 
dt
~nFib kon
Fib NP ½  Fib ½  {k
off
Fib NP:Fib ½ 
ð3Þ
The details of the model implementation and simulations are given
in the Material and Methods section.
The results of our simulations are shown in Figure 1. When the
evolution of the system is monitored for a relatively short time, two
distinct temporal regimes are observed. During the very fast initial
transient events (t,,0.05 s, Figure 1A), the concentration of the
free nanoparticles (NP) dramatically decreases due to the fast
formation of complexes between NP and each of the three
proteins. The concentration of these complexes appears fairly
stable in the first 20 s (Figure 1B). At t=10 s, 80.7% of the
available NP surface is covered by HSA, 18.9% by HDL and only
0.4% by Fib (Figure 1B). However, if the simulation is run for a
longer time, a very different scenario takes over (Figure 1C).
During the following ,14,000 s, corresponding to 3.9 h, a
redistribution of proteins at the NP surface is taking place, i.e.
the corona composition changes. After 3.9h, equilibrium is
reached and according to the simulation, 93.6% of the protein
corona is constituted of HDL, and the remaining 6.4% is HSA.
Fib does not significantly contribute to the corona, even at longer
equilibration times.
Table 1. Chemical, geometric and kinetic/thermodynamic parameters used in the model.
Concentration in blood (mg/mL)
[a] Radius (nm)
[b] Initial Concentration ([M])
[c] k
on (M
21 s
21)
[d] k
off (s
21)
[e] KA (M
21)
[f] ni
[g]
NP -3 5 1 8 610
29 -- - -
HDL 3
[h] 51 . 5 610
25 3610
4 3610
25 1610
9 256
HSA 40
[i] 46 . 0 610
24 2.4610
3 2.0610
23 1.2610
6 380
Fib 3
[i] 8.3 8.8610
26 2.0610
3 2.0610
23 1.0610
6 109
[a]average concentration found in human blood.
[b]protein radius calculated as if each protein were spherical.
[c]starting concentration in the simulation.
[d]association rate constant; see Materials and Methods section for details.
[e]dissociation rate constant: see Materials and Methods section for details.
[f]equilibrium constant (KA=k
on/k
off).
[g]ideal number of binding sites on the nanoparticle surface for the protein i.
[h]see Materials and Methods section for details.
[i]average values for a healthy adult human [18–20].
doi:10.1371/journal.pone.0010949.t001
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in the early transitory phase. This effect is removed if all such
factors are set equal to one, which corresponds to the case in which
all proteins are assumed to have the same number of binding sites
(or maximum coverage) on the NP surface. Figure 2A shows that
the initial transitory phase is then slowed compared to the case of
distinct ni’s, and it would take about 3 s to reach the first pseudo-
stable state. The same pattern as in Figure 1B is observed for the
early corona composition, except that both HDL (25.4%) and Fib
(1.2%) reach slightly higher levels. Interestingly, running the
simulations for a longer time shows that the final equilibrium is
reached faster, in ,10,800 s (3 hours), and the final levels (95.5%
of HDL and 4.4% of HSA, while Fib again is predicted to exert a
negligible effect) are similar to those found with different ni’s.
Recently, we experimentally investigated the role of NP size on the
NP-protein interaction, using the same NIPAM/BAM nanopar-
ticles (70 to 700 nm in diameter) and plasma. While the amount of
bound protein varied with particle size and scaled with the
Figure 1. Numerical simulation of the time evolution of the interaction between three human plasma proteins and 50:50 NIPAM/
BAM NP with 70 nm diameter. The values used for rate constants and correction factors accounting for the maximum number of binding sites on
the NP surface per protein are given in Table 1. The concentrations of NP (black-dotted), NP?HSA (red), NP?HDL (blue) and NP?Fib (green) as a function
of time are shown. A) First 0.05 s and B) first 20 s of simulation: the concentrations of free NP and proteins decrease fast (t,10 ms) due to the rapid
formation of NP?protein complexes. Initially HSA is the major contributor to the corona composition (80.7%) followed by HDL (18.9%) and Fib (0.4%).
C) First 20,000 s of simulation: a stable equilibrium is reached in about 4 hours, in which HDL is the most abundant protein in the corona (93.6%)
followed by HSA (6.4%).
doi:10.1371/journal.pone.0010949.g001
Figure 2. Numerical simulation of the time evolution of the interaction between three human plasma proteins and 50:50 NIPAM/
BAM NP with 70 nm diameter without the correction factors accounting for the maximum number of binding site on the NP surface
per protein (all ni’s=1). The rate constants used are given in Table 1. The concentrations of NP?HSA (red), NP?HDL (blue) and NP?Fib (green) as a
function of time are shown. A) First 20 s of simulation: the initial transitory phase develops slower than in the case shown in Figure 1. B) First 20,000 s
of simulation: the final equilibrium is reached faster compared to the case shown in Figure 1 and with a slightly different final composition of the
corona.
doi:10.1371/journal.pone.0010949.g002
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area was found to be the same for all sizes, except for a small
reduction observed for the smallest particles with 70 nm diameter
[3,5], indicating that surface curvature is not a major determinant
for the relative affinities of biological entities such as proteins and
apolipoproteins for the NIPAM/BAM copolymer particles over
the investigated size range. The results of the simulations
presented here, especially the limited dependence of ni’s for the
observed protein pattern at the final equilibrium, suggest that the
relative size of protein with respect to the particle mainly
influences the time required to reach the equilibrium. We should
also point out that the spherical approximation might be too
rough, especially for fibrinogen, which is an elongated protein.
Recent data concerning other nanoparticles [7,8] seem to support
the hypothesis that Fib binds to the nanoparticle surface with its
short ends, hence reducing the effective cross-section in favor of
increased maximum number of binding sites. To probe the effect
of this different binding mode on the overall corona dynamics we
performed two sets of simulations with nFib increased 10- and 100-
fold, respectively, relative to the previous value (Figure 3). When
the number of binding sites for Fib is increased 10-times
(Figure 3A), no significant difference is observed on the short
and long-time course with respect to the original case shown in
Figure 1. The main difference is in fact a slightly increased level of
Fib concentration in the early corona, which however does not
perturb the timing and the composition of the hard corona.
However, when the number of binding sites for Fib is increased
100-times (Figure 3B), the composition of the early corona is
predicted to change significantly. In detail, HSA would cover
63.8% of the NP, while Fib and HDL would cover 22.3% and
13.9% respectively. Hence, in this case, the concentration of
nanoparticle-bound Fib is expected to exceed that of NP-HDL in
the early corona. The simulations nevertheless suggest that the
timing and the composition of the hard corona are only marginally
affected, and the process of reaching the equilibrium appears to be
slightly slowed down with a final detectable level for Fib (2.3%).
To experimentally characterize the composition of the hard
corona formed around a nanoparticle the unbound or weakly
bound proteins must first be removed. This is done using a
purification scheme that includes several centrifugation and
washing steps [3,5]. The whole process takes ,15–20 min (for
details see Material and Methods). Thus the very early events on a
sub-second to minute time-scale can not be experimentally
investigated by this technique. Unbound and weakly associated
proteins are washed away from the protein-nanoparticle com-
plexes during this process, however, also a fraction of the proteins
that participate in building up the hard corona, apolipoproteins in
the case of copolymer particles, are washed away in the process.
This means that for the very early events it is not possible to make
direct correlation between the simulated results and quantitative
results obtained experimentally by SDS-PAGE gels. The model
shows that the initial corona is mainly built up by HSA, which is
not surprising considering the abundance of serum albumin in
blood. However, the interaction between HSA and the copolymer
particles is relatively weak (Table 1). Pull down experiments, which
measure the concentration in the supernatant after the particles
have been pelleted, with particles mixed with single protein
solutions of HDL, HSA, and apolipoprotein A-I show that both
HDL and apolipoprotein A-I concentrations are reduced (i.e. they
interact strongly with the particles and are pelleted together with
the particles) while the HSA concentration in the supernatant
remains unchanged (unpublished data). The interaction between
HSA and the copolymer particles is not strong enough for the
early, very dynamic, corona to withstand the purification scheme.
The corona evolves with time, as the model shows, going from a
soft corona dominated by HSA to a hard corona dominated by
apolipoproteins (HDL). Figure 4 shows the hard corona around
the copolymer particles after 30 s (+3 min centrifugation)
Figure 3. Numerical simulation of the time evolution of the interaction between three human plasma proteins and 50:50 NIPAM/
BAM NP with 70 nm diameter with different number of binding sites for Fib. The values used for rate constants and correction factors
accounting for the maximum number of binding sites on the NP surface for HSA and HDL are given in Table 1. The number of maximum binding sites
for Fib on the NP surface are A) nFib=1090 (10-fold increase) and B) nFib=10,900 (100-fold increase). The concentrations of NP?HSA (red), NP?HDL
(blue) and NP?Fib (green) as a function of time are shown. The inset in each panel reports the first 20 s to show the predicted composition of the
early corona.
doi:10.1371/journal.pone.0010949.g003
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detected apolipoprotein A-I, A-IV and E have increased compared
to the amount of HSA for 6 h sample compared to the 30 s
sample, in line with the current modeling.
The results from the simulations clearly show that the temporal
development of the corona strongly depends on the association/
dissociation rates of each protein, which in turn determine the
time required to reach the equilibrium state. Hence, it is
fundamental that the rate constants used in the model arise from
directly measured kinetic parameters rather than rely on
equilibrium data such as affinity measurements. For the
simulations in this work, the association and dissociation rate
constants were experimentally determined for HDL, HSA and Fib
(see the Materials and Methods section). Figure 5 illustrates the
importance of distinguishing between kinetic and equilibrium data
and shows how a change in k
on and k
off values, at constant KA,
affects the time to reach equilibrium. By using the experimentally
determined k
on and k
off values the affinity for HDL is calculated to
be 10
9 M
21 (Table 1). However, different combinations of kinetic
constants yield the same affinity. Figure 5A shows the simulated
case with a 10
9 M
21 HDL-NP affinity, but in this case both k
on
and k
off are assumed to be 10-fold higher compared to the
experimentally determined values (Table 1). The graph inset
shows a completely different early corona, in which HDL already
prevails over the two other protein types. Moreover, while a very
similar corona composition is expected at equilibrium (compare
with equilibrium levels in Figure 1B), the modified kinetics allow
the equilibrium to be reached much faster, in about 3000 s
(50 min). On the other hand, using the same affinity but lowering
both k
on and k
off 10 times, leads to a completely different scenario
(Figure 5B). The early corona would be almost entirely formed by
HSA (see inset) and the same final equilibrium, similar to the one
predicted with experimentally determined parameters (se
Figure 1B), would be reached much slower, in ,10
5 s (28 hours).
Hence, in order for the simulations to be realistic we conclude that
it is essential to collect robust experimental data that are not
limited to affinity measurements but include direct assessment of
kinetic parameters.
Overall, the results of the simulations presented in this work are
consistent with our recent experimental findings. Indeed, by SDS-
page we showed that HSA, despite its higher concentration that is
reflected by initially more abundant binding, is soon replaced by
Figure 4. Hard corona around the copolymer particles after 30 s and 6 h of incubation in human plasma. A) 12% SDS-gel showing; a:
human plasma diluted 20 times (5 ml added to the gel), b: MW standard, c: copolymer particles incubated 30 s in plasma, d: copolymer particles
incubated 6 h in plasma. Arrow 1–4 indicates the gel bands for serum albumin, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I,
respectively. B) traces for lane c and d in panel A as obtained using ImageJ (see the Materials and Methods section). The arrows indicate the same
proteins as in panel A.
doi:10.1371/journal.pone.0010949.g004
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AIV and E [3] (which all come from the interaction of HDL with
the copolymer particles) [5]. We further observed that the
interaction with HDL is specific, as HDL binds to copolymer
nanoparticles with much higher affinity than other lipoproteins,
like low density lipoprotein or very low density lipoprotein,
probably mediated by apolipoprotein A-I, which is its major
component [4]. Hence, the results of our simulations (Figure 1)
rationalize and quantitatively confirm these prior observations.
The advantage of the simple model presented here is that it can
easily be modified to mimic, for instance, the interaction of the NP
corona with a novel biological fluid or compartment once new
data will be available. In that case the novel initial conditions
would correspond to the equilibrium state outlined from the
simulations presented here. By adding novel molecular species to
the model, the time evolution of the whole system can be
monitored and the results of simulations experimentally tested.
Moreover, once a proper overall kinetic description is achieved for
the corona around a NP in a certain biological environment, the
whole model could be inserted into a biochemical pathway and
used to predict the perturbations exerted by the corona on that
pathway. Very recently the procedure used to build the model
presented here has been successfully tested in a novel bottom-up
strategy for simulating a complex signal transduction pathway
such as that of phototransduction in vertebrate cells [9] indicating
that when sufficient experimental information is available it is
possible to bridge between the biochemical and cellular levels, thus
increasing the relevance and the potential of modeling for general
nanomedicine and systems biology purposes.
Nanoscience is expected to deeply affect medicine and
biotechnology in the near future. Solid modeling procedures
based on validated techniques are expected to provide valuable
insights into the molecular mechanisms of nanoparticle-cell/tissue
interactions and sound predictions of novel properties and
applications.
Materials and Methods
Surface Plasmon Resonance spectroscopy: measurement
of the kinetic parameters for the NP-HDL interaction
Surface plasmon resonance was employed to study HDL
association to and dissociation from the nanoparticle. HDL was
used in the form of reconstituted HDL (rHDL) particles. rHDL
was prepared as previously described [10]. Briefly, phospholipids
(phosphatidylcholine) were dried and resuspended in PBS buffer
with n-octyl-b-D-glucopyranoside. Solubilized lipids were mixed
with apoA–I (30:1 phospholipid/apoA–I molar ratio) and
dialyzed.
A BIAcore 3000 instrument (General Healthcare Life Science
TM) was used and the experimental conditions were the same as
in our previous work [1] in order to allow a direct comparison
between the newly measured kinetic parameters and those of other
protein-nanoparticle interactions previously characterized. In
brief, thiol-linked nanoparticles were dissolved in 20 mM sodium
phosphate buffer,100 mM NaCl (pH 7.5), on ice and applied to
gold surface. Alkylated (to avoid coupling to gold via free thiols
groups) single proteins diluted in flow buffer (10 mM Tris/HCl,
pH 7.4, 3 mM EDTA, 150 mM NaCl, 0.005% Tween-20) were
injected for 30 min to study the association kinetics. After 30 min,
buffer was flowed over the sensor chip surface for 10–24 h to study
dissociation kinetics. Results from kinetics experiments are
reported in Table 1.
Human plasma
Human blood was withdrawn from seemingly healthy humans,
who all signed a consent stating that their blood could be used in
scientific research projects, into vessels pre-treated with EDTA-
solution. The blood vessels where centrifuged for 5 min at 800
RCF. The supernatants (the plasma) were transferred to new
vessels and stored in 280uC freezer until time of use. Before use,
the plasma vessel was thawed and centrifuged for 3 min at 16.1
Figure 5. Two simulations of NP-protein interaction kinetics showing the time evolution of the occupancy of HDL (blue), HSA (red)
and Fib (green) on the nanoparticle surface, using the same affinity but different kinetics for HDL. The affinity for HDL-NP interaction is
1610
9 M
21 while that for HSA-NP and Fib are respectively 1.2610
6 M
21 and 1610
6 M
21 (Table 1). The association and dissociation rate constants of
HDL are modified with respect to the original values (k
on=3 610
4 M
21 s
21and k
off=3 610
25 s
21) to be 10 times higher in panel A) and 10 times lower
in panel B). The insets in each panel show the composition of the early corona (t=20 s).
doi:10.1371/journal.pone.0010949.g005
Nanoparticle-Protein Corona
PLoS ONE | www.plosone.org 6 June 2010 | Volume 5 | Issue 6 | e10949kRCF and the supernatant was transferred to a new vessel. Lund
University Hospital ethic committee has approved all experiments
in this article conducted with human plasma.
Detection of the hard protein corona
Identification of protein in the hard corona was performed as
previously reported [3] and described below. Lyophilized 70 nm
copolymer (NIPAM:BAM 50:50) particles were dissolved on ice in
PBS (10 mM phosphate, 150 mM NaCl, 1 mM EDTA, pH 7.5)
to a concentration of 10 mg/mL. The particle solution was kept
on ice throughout the experiment. 800 mL of human plasma was
mixed with 100 mL of the particle solution. The mixture was
incubated for 30 s (first sample) or 6 h (second sample) followed by
centrifugation at 15 kRCF for 3 minutes. The plasma was
discarded, the pellet resuspended in 1 mL PBS, and the solution
was transferred to a new vessel and centrifuged as above. This
washing step was repeated three times with change of vessel each
time to avoid artifacts from protein bound to the vessel wall.
Proteins were desorbed from the nanoparticles in the final pellet by
adding 30 mL SDS sample buffer and incubating at 100uC for 5
minutes, after which 10 mL were applied to SDS PAGE
(Figure 4). The intensity of each protein band was estimated
through digital gel scan using ImageJ software [11] (http://rsb.
info.nih.gov/ij/), and proteins identified by mass spectrometry [1]
(see Table 2). The experiments were repeated six times with
comparable results, and Figure 4 reports a representative outcome
from such experiments.
Model building and simulations
A kinetic model of the nanoparticle-protein corona was built by
combining the rate equations for association and dissociation of
proteins with nanoparticle, with concentrations, individual values
of k
on, k
off and maximum stoichiometry at full occupancy in a single
layer as described in Table 1. The building of the kinetic model
was carried out by means of SBTOOLBOX2 for Matlab (http://
www.sbtoolbox2.org) [12]. This tool allows specifying the model
directly through biochemical reaction equations that can then be
converted into the ODEs to be numerically solved. All numerical
simulations in this work were carried out within the framework of
the SBTOOLBOX2 following an automatic generation of
compiled C-code models, based on the CVODE integrator from
SUNDIALS [13].
Calculation of the HDL concentration in blood
High density lipoprotein (HDL) is defined as the lipoprotein
fraction with a density range between 1.063 to 1.21 g/mL. The
HDL fraction comprises two major fractions: HDL2 (1.063–
1.125 g/mL) and HDL3 (1.125–1.21 g/mL). HDL2 and HDL3
have different sizes and molecular weights [14]. They are
composed of complexes of proteins, cholesterol, phospholipids,
cholesteryl ester, and triglycerides [15]. The HDL concentration is
normally indirectly measured via the concentration of cholesterol,
either for total HDL or for each sub fraction. In this work the
HDL concentration was used in the simulation, since Hellstrand et
al. [4] have shown that HDL binds to the copolymer particles. The
HDL concentration was calculated by using the cholesterol
molecular weight, cholesterol content values [15] for HDL2 and
HDL3, and reported levels of HDL2- and HDL3-cholesterol for
healthy control groups [11,16–17].
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